2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Leukemia, Myeloid, Acute
134
Precursor Cell Lymphoblastic Leukemia-Lymphoma
116
Myelodysplastic Syndromes
112
Leukemia, Lymphocytic, Chronic, B-Cell
102
Lymphoma, Non-Hodgkin
98
Hodgkin Disease
95
Leukemia
86
Multiple Myeloma
85
Lymphoma
72
Lymphoma, Mantle-Cell
67
Lymphoma, Follicular
67
Lymphoma, Large B-Cell, Diffuse
64
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
60
Myeloproliferative Disorders
58
Lymphoma, B-Cell, Marginal Zone
58
Burkitt Lymphoma
53
Leukemia, Myelomonocytic, Chronic
51
Congenital Abnormalities
51
Leukemia, Myeloid, Chronic-Phase
49
Lymphoma, Large-Cell, Immunoblastic
46
Leukemia, Myeloid, Accelerated Phase
43
Hematologic Neoplasms
42
Anemia, Refractory, with Excess of Blasts
40
Graft vs Host Disease
39
Primary Myelofibrosis
36
Waldenstrom Macroglobulinemia
34
Neoplasms, Plasma Cell
33
Blast Crisis
33
Recurrence
30
Lymphoma, T-Cell, Cutaneous
30
Interventions
Infliximab
4
vedolizumab
3
Fecal Microbiota Transplantation
3
Prednisone
2
Methylprednisolone
2
LDP-02
2
Immunoglobulin G
2
Disulfides
2
CT-P13
2
tocilizumab
1
prednylidene
1
fish oil triglycerides
1
deltacortene
1
Standard of Care
1
Practice Guidelines as Topic
1
Photopheresis
1
Mycophenolic Acid
1
Methylprednisolone Hemisuccinate
1
Methoxsalen
1
Loperamide
1
Injections
1
Endoscopy
1
Diagnosis
1
Colonoscopy
1
Cell- and Tissue-Based Therapy
1
Azathioprine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colitis
×
Mycophenolic Acid
×
Clear all
NCT07619898
2026-06-02
PHOENIX-ECP
Therakos LLC
Phase 2
Not yet recruiting
112 enrolled